1 November 2018

Wikipedia The Radboud Center for Oncology is initiating the Radboud Biobank Oncology in the Radboudumc. This oncology biobank will be part of the Radboud Biobank.

The Radboud Center for Oncology is initiating the Radboud Biobank Oncology in the Radboudumc. This oncology biobank will be part of the Radboud Biobank. Biomaterial and associated clinical data will be collected of each patient with cancer who visits the Radboudumc for diagnosis or treatment. The Radboud Biobank Oncology aims to make a significant impact on cancer care. Peggy Manders (manager of the Radboud Biobank) is responsible for the implementation of this biobank initiative.
 

Related news items


Introduction:

17 January 2019

A new face at the Radboud Biobank!

read more

Policy regarding the financing of new biomaterials

17 January 2019

All initial costs related to patient sampling and the collection of biomaterials are covered by individual academic departments. Read more about the costs covered by the Radboud Biobank.

read more

Need a transfer agreement for external partners? For the transfer of biomaterial and/or data to an external partner a material and data transfer agreement (MTA/DTA) must be used.

17 January 2019

For the transfer of biomaterial and/or data to an external partner a material and data transfer agreement (MTA/DTA) must be used.

read more

Amount of DNA upon request

17 January 2019

Upon request of DNA an applicant must indicate how many μgs of DNA is needed.

read more

Website for patients about biobanking

1 November 2018

In October a new website was published for patients

read more

New sub-biobank: Haemophilia Pearl

1 November 2018

The Radboud Biobank has added a new sub-biobank to the collection: the Haemophilia Pearl which is part of the Parelsnoer Institute

read more